Bio Farma: Vaccines Distributed but Awaiting BPOM Approval for Use

Translator:

Editor:

Petir Garda Bhwana

  • Font:
  • Ukuran Font: - +
  • TEMPO.CO, Jakarta - Following news of the nationwide distribution of vaccines, state-pharmaceutical firm Bio Farma on Monday assures the vaccination of the Sinovac Covid-19 vaccine will only be permitted after the emergency use authorization has been issued by the Food and Drugs Monitoring Agency (BPOM).

    “Even though the vaccines have been distributed, the use must wait for an EUA,” said the Bio Farma Covid-19 vaccine spokesperson, Bambang Herianto, on January 4. 

    The process which according to Herianto is being processed by the BPOM as the agency continues to closely monitor the interim analysis of the vaccine’s clinical trials for at least three months in order to obtain conclusive data on its safety that complies with requirements set by the World Health Organization (WHO).

    In its initial phase, Bio Farma has distributed 714,240 doses of the Sinovac vaccine vials to 32 Indonesian provinces from January 3 - January 4. 

    Also Read: Bio Farma Reacts to Rampant Ads on Pre-order Offer for Covid-19 Vaccination

    FRANCISCA CHRISTY ROSANA